Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

5.53USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$5.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
90,934
52-wk High
$18.30
52-wk Low
$4.06

Chart for

About

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121... (more)

Overall

Beta: --
Market Cap(Mil.): $547.77
Shares Outstanding(Mil.): 24.23
Dividend: --
Yield (%): --

Financials

  KALA.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.67 -- --
ROI: -- 8.99 14.48
ROE: -- 10.14 15.99

FDA approves Kala Pharma's eye pain drug

The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

Aug 23 2018

U.S. FDA approves Kala Pharma's eye pain drug

Aug 23 The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

Aug 23 2018

Earnings vs. Estimates